Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Bernett

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Proteins|September 24, 2004
An atomic resolution structure for human fibroblast growth factor 1Matthew J Bernett, Thayumanasamy Somasundaram, Michael Blaber
The Journal of Biological Chemistry|May 2, 2002
Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous systemMatthew J Bernett, Sachiko I Blaber, Isobel A Scarisbrick, et al.
Proteins|January 15, 2005
1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate bindingGurunathan Laxmikanthan, Sachiko I Blaber, Matthew J Bernett, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 23, 2004
Targeting kallikrein 6 proteolysis attenuates CNS inflammatory diseaseSachiko I Blaber, Bogoljub Ciric, George P Christophi, et al.
Biochemistry|January 23, 2002
Enzymatic properties of rat myelencephalon-specific proteaseSachiko I Blaber, Isobel A Scarisbrick, Matthew J Bernett, et al.
Molecular Cancer Therapeutics|May 13, 2024
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell ExpansionJi Li, Robyn Clark, Dionysos Slaga, et al.
Blood|July 10, 2010
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignanciesHolly M Horton, Matthew J Bernett, Matthias Peipp, et al.
Cancer Research|October 3, 2008
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemiaHolly M Horton, Matthew J Bernett, Erik Pong, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15Louis R Joslyn, Mohammad Jafarnejad, Rajbharan Yadav, et al.
Methods (San Diego, Calif.)|October 27, 2018
A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formatsGregory L Moore, Matthew J Bernett, Rumana Rashid, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Proteins|September 24, 2004
An atomic resolution structure for human fibroblast growth factor 1Matthew J Bernett, Thayumanasamy Somasundaram, Michael Blaber
The Journal of Biological Chemistry|May 2, 2002
Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous systemMatthew J Bernett, Sachiko I Blaber, Isobel A Scarisbrick, et al.
Proteins|January 15, 2005
1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate bindingGurunathan Laxmikanthan, Sachiko I Blaber, Matthew J Bernett, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 23, 2004
Targeting kallikrein 6 proteolysis attenuates CNS inflammatory diseaseSachiko I Blaber, Bogoljub Ciric, George P Christophi, et al.
Biochemistry|January 23, 2002
Enzymatic properties of rat myelencephalon-specific proteaseSachiko I Blaber, Isobel A Scarisbrick, Matthew J Bernett, et al.
Molecular Cancer Therapeutics|May 13, 2024
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell ExpansionJi Li, Robyn Clark, Dionysos Slaga, et al.
Blood|July 10, 2010
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignanciesHolly M Horton, Matthew J Bernett, Matthias Peipp, et al.
Cancer Research|October 3, 2008
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemiaHolly M Horton, Matthew J Bernett, Erik Pong, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15Louis R Joslyn, Mohammad Jafarnejad, Rajbharan Yadav, et al.
Methods (San Diego, Calif.)|October 27, 2018
A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formatsGregory L Moore, Matthew J Bernett, Rumana Rashid, et al.
Pageof 2